† School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China ‡ Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China Article Views are the ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that Leqembi sales are expected to total JPY 76.5 ...

Detailed price information for Acumen Pharmaceuticals Inc (ABOS-Q) from The Globe and Mail including charting and trades.

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in ...

Preclinical data indicate that vanutide cridificar generates N-terminal anti-Aβ antibodies but no Aβ-directed T cell response, and that it reverses cognitive impairment in murine models of AD. Elan ...

FRIDAY, May 9, 2025 (HealthDay News) -- Disclosure of amyloid-β (Aβ) status seems not have a negative psychological impact, according to a study published online May 7 in Alzheimer's & Dementia.

While the data regarding antibody sequence preferences for distinct amyloid-beta regions and aggregation states are convincing, a thorough revision of the manuscript would help to highlight the key ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that Leqembi sales are expected to total JPY 76.5 billion (approximately SEK 5.1 billion) ...

因此，我们需要一种更加精准、无创的诊断手段，来捕捉阿尔兹海默症的早期迹象。 这时，PET检查（特别是Aβ-PET）便成为了我们的得力助手。Aβ-PET，即淀粉样蛋白正电子发射断层显像，能够可视化显示大脑中的β-淀粉样蛋白（Aβ）沉积情况。这些异常的蛋白 ...